{
  "id": 3648,
  "text": "A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer.Gynecol Oncol 133, 117-123 (2014).1644.Monk, B.J., et al.Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer.Gynecol Oncol 133, 117-123 (2014).1644.Monk, B.J., et al.Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study.\n\n<question>: ",
  "ChatGPT_response_0": "根据第三期试验结果显示，针对宫颈癌复发或转移性患者的四种顺铂含有的双药联合方案都是经过严格研究的。这些方案可能包括不同的化疗药物组合，如顺铂和紫杉醇。然而，具体选择哪种方案应考虑患者的个体情况，包括疾病特征、耐受性和禁忌症等因素。因此，在决定治疗方案时，最好咨询医疗专家以获取更具体的建议。",
  "query": "对于宫颈癌复发或转移性患者，针对四种顺铂含有的双药联合方案的第三期试验结果如何呢？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于宫颈癌复发或转移性患者，针对四种顺铂含有的双药联合方案的第三期试验结果如何呢？\n\n<reference text>: A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer.Gynecol Oncol 133, 117-123 (2014).1644.Monk, B.J., et al.Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study.\n\n<reply>: ",
  "response": "根据第三期试验结果显示，针对宫颈癌复发或转移性患者的四种顺铂含有的双药联合方案都是经过严格研究的。这些方案可能包括不同的化疗药物组合，如顺铂和紫杉醇。然而，具体选择哪种方案应考虑患者的个体情况，包括疾病特征、耐受性和禁忌症等因素。因此，在决定治疗方案时，最好咨询医疗专家以获取更具体的建议。"
}